Fosfomycin: An oral agent for urinary infection caused by extended spectrum beta-lactamase producing organisms

Journal of Infection

Volumn 60, Issue 4, 2010, Pages 308-309

  Hutley, E J ^a   Chand, M A ^b   Hounsome, G ^a   Kelsey, M C ^b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b WHITTINGTON HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Antimicrobial; Extended spectrum beta lactamase; Fosfomycin; Oral; Urinary tract infection

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFALEXIN; CIPROFLOXACIN; FOSFOMYCIN; NITROFURANTOIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; DRUG CONTRAINDICATION; DRUG SAFETY; ENTEROBACTER; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FOOD AND DRUG ADMINISTRATION; HUMAN; ITALY; KLEBSIELLA; LETTER; NONHUMAN; PREVALENCE; SERRATIA; TREATMENT INDICATION; UNITED KINGDOM; URINALYSIS; URINARY TRACT INFECTION; BIOSYNTHESIS; DRUG EFFECT; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NOTE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FOSFOMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; URINARY TRACT INFECTIONS;

EID: 77952556628     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.01.006     Document Type: Letter

References (7)

1. Falagas M.E., Kotsantis I.K., Vouloumanou E.K., Rafailidis P.I. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: A meta-analysis of randomized controlled trials. J Infect 2009, (i):91-102.
2. Woodford N., Ward M.E., Kaufmann M.E., Turton J., Fagan E.J., James D., et al. Community and Hospital Spread of Escherichia coli producing CTX-M extended β-lactamases in the UK. J Antimicrob Chemother 2004, 54(4):735-743.
3. Schito G.C., Naber K.G., Botto H., Palou J., Mazzei T., Gualco L., et al. The ARSEC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 2009 Jun 6.
4. Garau J. Other microbials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. Clin Microbiol Infect 2008 Jan, 14(Suppl. 1):198-202.
5. Galatti L., Sessa A., Mazzaglia G., Pecchioli S., Rossi A., Cricelli C., et al. Antibiotic prescribing for acute and recurrent cystitis in primary care: a 4 year descriptive study. J Antimicrob Chemother 2006, 57:551-556.
6. FDA licensing information on fosfomycin Available at:, [accessed 02.07.09]. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm%3Ffuseaction%3DSearch.DrugDetails.
7. British Society for Antimicrobial Chemotherapy Standardised Disc Susceptibility Testing Method Version 8 available at:, [accessed 02.07.09]. http://www.bsac.org.uk/susceptibility_testing/bsac_standardized_disc_susceptibility_method.cfm.